Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies.
- Published In:
- Diabetes, obesity & metabolism, 25(4), 965-974 (2023)
- Authors:
- Lingvay, Ildiko(13), Cheng, Alice Yy, Levine, Joshua A(2), Gomez-Valderas, Elisa, Allen, Sheryl E, Ranta, Kari, Torcello-Gómez, Amelia, Thieu, Vivian T
- Database ID:
- RPEP-07122
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07122APA
Lingvay, Ildiko; Cheng, Alice Yy; Levine, Joshua A; Gomez-Valderas, Elisa; Allen, Sheryl E; Ranta, Kari; Torcello-Gómez, Amelia; Thieu, Vivian T. (2023). Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies.. Diabetes, obesity & metabolism, 25(4), 965-974. https://doi.org/10.1111/dom.14943
MLA
Lingvay, Ildiko, et al. "Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies.." Diabetes, 2023. https://doi.org/10.1111/dom.14943
RethinkPeptides
RethinkPeptides Research Database. "Achievement of glycaemic targets with weight loss and withou..." RPEP-07122. Retrieved from https://rethinkpeptides.com/research/lingvay-2023-achievement-of-glycaemic-targets
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.